Psychedelic-induced mystical experiences: An interdisciplinary discussion and critique

Abstract

Contemporary research on serotonergic psychedelic compounds has been rife with references to so-called ‘mystical’ subjective effects. Several psychometric assessments have been used to assess such effects, and clinical studies have found quantitative associations between ‘mystical experiences’ and positive mental health outcomes. The nascent study of psychedelic-induced mystical experiences, however, has only minimally intersected with relevant contemporary scholarship from disciplines within the social sciences and humanities, such as religious studies and anthropology. Viewed from the perspective of these disciplines—which feature rich historical and cultural literatures on mysticism, religion, and related topics—‘mysticism’ as used in psychedelic research is fraught with limitations and intrinsic biases that are seldom acknowledged. Most notably, existing operationalizations of mystical experiences in psychedelic science fail to historicize the concept and therefore fail to acknowledge its perennialist and specifically Christian bias. Here, we trace the historical genesis of the mystical in psychedelic research in order to illuminate such biases, and also offer suggestions toward more nuanced and culturally-sensitive operationalizations of this phenomenon. In addition, we argue for the value of, and outline, complementary ‘non-mystical’ approaches to understanding putative mystical-type phenomena that may help facilitate empirical investigation and create linkages to existing neuro-psychological constructs. It is our hope that the present paper helps build interdisciplinary bridges that motivate fruitful paths toward stronger theoretical and empirical approaches in the study of psychedelic-induced mystical experiences.

5-MeO-DMT for post-traumatic stress disorder: a real-world longitudinal case study

“…Furthermore, the subject endorsed a strong and complete mystical experience. While the mechanism underlying her therapeutic response is unknown, it may be explained, in part, by the epistemological or ‘noetic quality’ of mystical states, occasioned by 5-MeO-DMT ( 39 ). These psychological states are characteristic of psychedelics, namely serotonergic compounds ( 39 ); have been shown to correlate, mediate, and predict therapeutic efficacy ( 40 ); and include feelings of transcendence, ego dissolution, and ineffability as well as unity, love, and peace ( 41 ).…”

“…While the mechanism underlying her therapeutic response is unknown, it may be explained, in part, by the epistemological or ‘noetic quality’ of mystical states, occasioned by 5-MeO-DMT ( 39 ). These psychological states are characteristic of psychedelics, namely serotonergic compounds ( 39 ); have been shown to correlate, mediate, and predict therapeutic efficacy ( 40 ); and include feelings of transcendence, ego dissolution, and ineffability as well as unity, love, and peace ( 41 ). Thus, people have rated mystical experiences in their top five most important life events, in terms of personal meaning and spiritual significance, next to giving birth or losing a loved one ( 42 , 43 ).…”

Unraveling Psychedelic Responses: Targeted Protein Degradation and Genetic Diversity

“…While significant progress has been made, the field of psychedelic research still faces many unanswered questions. The advent of TPD technologies introduces new exploratory avenues and the potential for personalized therapeutic approaches, leading to a deeper understanding of these powerful substances …”

Community-based psychedelic integration and social efficacy: An ethnographic study in the Southeastern United States

“…They include classic psychedelics (psilocybin, mescaline, DMT, and LSD) as well as ketamine and MDMA, which are not serotonergic psychedelics but have similar pharmacological action (Nichols et al, 2023). Therapeutically, psychedelics hold promise for treating a range of mental health conditions (Ko, Knight, Rucker, & Cleare, 2022;Mosurinjohn, Roseman, & Girn, 2023), including depression (Carhart-Harris et al, 2018;Varley, 2019) and substance use (Nichols, Johnson, & Nichols, 2017). Psychedelics are also associated with enhancement of a sense of wellbeing in otherwise healthy people (Wiepking, de Bruin, & Ghit ¸ȃ, 2023) and an increase in a sense of spiritual connectedness (Griffiths, Hurwitz, Davis, Johnson, & Robert, 2019).…”